Skip to main content
. 2021 Jun 15;6(2):102. doi: 10.3390/tropicalmed6020102

Table 2.

Factors associated with screening for ‘high risk of severe illness @ at notification among adults (≥15 years) with TB (without known drug-resistant disease at diagnosis) from public health facilities of 16 districts in Karnataka, India, 15 October to 30 November 2020 (n = 3020).

Factors * Total Screened (Yes) PR (95%CI) aPR ** (95%CI)
n (%)
Total 3020 1531 (50.7)
Age in years
15–24 476 234 (49.2) Ref #
25–34 611 305 (49.9) 1.02 (0.90, 1.15)
35–44 619 321 (51.9) 1.05 (0.94, 1.19)
45–54 575 290 (50.4) 1.03 (0.91, 1.16)
55–64 416 207 (49.8) 1.01 (0.89, 1.16)
≥65 323 174 (53.9) 1.10 (0.96, 1.26)
Gender
Men 2039 1045 (51.3) Ref #
Women 981 486 (49.5) 0.97 (0.90, 1.04)
Test used for diagnosis
Rapid molecular tests 1630 789 (48.4) Ref Ref
Microscopy/Culture 566 294 (51.9) 1.07 (0.98, 1.18) 1.07 (0.97, 1.18)
Chest Radiograph 272 168 (61.8) 1.28 (1.15, 1.42) ^ 1.09 (0.98, 1.20)
Others 552 280 (50.7) 1.05 (0.95, 1.15) 1.16 (1.05, 1.27) ^
Bacteriological confirmation
Yes 2284 1135 (49.7) Ref #
No 736 396 (53.8) 1.08 (1.00, 1.17)
Site of TB
Pulmonary 2186 1210 (55.4) Ref &
Extrapulmonary 667 318 (47.4) 0.86 (0.79, 0.94) ^
Missing 167 3 (1.8) 0.03 (0.01, 0.10) ^
Previous treatment
Yes 474 248 (52.3) 1.04 (0.94, 1.14) #
No 2546 1283 (50.4) Ref
HIV
Positive 225 109 (48.4) 0.90 (0.79, 1.04) 0.86 (0.76, 0.98) ^
Negative 2531 1358 (53.7) Ref
Unknown 264 64 (24.2) 0.45 (0.36, 0.56) ^ 0.85 (0.69, 1.05)
DM
Positive 505 274 (54.3) 0.99 (0.91, 1.09) 0.99 (0.91, 1.07)
Negative 2086 1138 (54.6) Ref
Unknown 429 119 (27.7) 0.51 (0.43, 0.60) ^ 0.82 (0.71, 0.95) ^
Bank details available
Yes 2353 1281 (54.4) Ref
No 667 250 (37.5) 0.69 (0.62, 0.76) ^ 0.87 (0.79, 0.95) ^
Peripheral Health Institute—Notification facility
District/Teaching hospital 1942 847 (43.6) 0.65 (0.60, 0.70) ^ 0.87 (0.81, 0.94) ^
Sub-district level hospital 769 517 (67.2) Ref
Primary health Centre 206 100 (48.5) 0.72 (0.62, 0.84) ^ 1.11 (0.95, 1.29)
Days to notify from diagnosis
Within a day 2160 1098 (50.8) Ref
1–6 day 632 352 (55.7) 1.10 (1.01, 1.19) ^ 1.07 (0.99, 1.16)
7–13 113 54 (47.8) 0.94 (0.77, 1.14) 0.98 (0.82, 1.18)
14–27 73 22 (30.1) 0.59 (0.42, 0.84) ^ 0.71 (0.52, 0.98) ^
≥28 42 5 (11.9) 0.23 (0.10, 0.53) ^ 0.31 (0.14, 0.68) ^
Treatment started
Yes 2853 1528 (53.6) Ref
No 167 3 (1.8) 0.03 (0.01, 0.10) ^ 0.04 (0.01, 0.17) ^
Transferred out of district
Yes 521 156 (29.9) 0.54 (0.47, 0.62) ^ 0.70 (0.62, 0.80) ^
No 2499 1375 (55.0) Ref

TB—tuberculosis, PTB—pulmonary TB, EPTB—extrapulmonary TB, LPA—line probe assay, HIV—human immunodeficiency virus, DM—Diabetes mellitus; PR—crude prevalence ratio, aPR—adjusted PR; @ defined as filling and syncing of screening details in a mobile application irrespective of the extent of missing data; * source is the routinely collected baseline data in NIKSHAY updated as on 15 December 2020; ** modified Poisson regression with robust variance estimation, results have been adjusted for district;# Variables with crude p value ≥ 0.05 (Chi square test) were not included in the adjusted analysis;& excluded because of variance inflation factor >10; ^ p < 0.05.